James F.  Hinrichs net worth and biography

James Hinrichs Biography and Net Worth

Director of Acutus Medical
Jim Hinrichs has served as a member of our board of directors and chair of our Audit Committee since October 2019. Hinrichs has over 25 years of corporate finance experience and previously served as Executive Vice President and Chief Financial Officer of Alere, Inc., a publicly traded, global diagnostics company, from April 2015 until its sale to Abbott Labs for approximately $8 billion in October 2017. Prior to joining Alere, Inc., Hinrichs served as Chief Financial Officer of CareFusion Corp., a publicly traded medical device company, from December 2010 until its sale to Becton Dickenson for $12 billion in March of 2015. Before that, Hinrichs held various financial leadership positions at CareFusion, Cardinal Health and Merck & Co. He is a member of the Board of Directors, and Audit Committee Chair, of Orthofix and a Member of the Board of Directors, and Compensation Committee Chair, of Integer Holdings. He holds graduate and undergraduate degrees in business from Carnegie-Mellon University.

What is James F. Hinrichs' net worth?

The estimated net worth of James F. Hinrichs is at least $14,826.93 as of September 14th, 2023. Mr. Hinrichs owns 86,153 shares of Acutus Medical stock worth more than $14,827 as of April 19th. This net worth evaluation does not reflect any other assets that Mr. Hinrichs may own. Learn More about James F. Hinrichs' net worth.

How do I contact James F. Hinrichs?

The corporate mailing address for Mr. Hinrichs and other Acutus Medical executives is 2210 FARADAY AVE SUITE 100, CARLSBAD CA, 92008. Acutus Medical can also be reached via phone at 442-232-6080 and via email at [email protected]. Learn More on James F. Hinrichs' contact information.

Has James F. Hinrichs been buying or selling shares of Acutus Medical?

James F. Hinrichs has not been actively trading shares of Acutus Medical during the last quarter. Most recently, on Monday, November 15th, James F. Hinrichs bought 40,000 shares of Acutus Medical stock. The stock was acquired at an average cost of $3.78 per share, with a total value of $151,200.00. Learn More on James F. Hinrichs' trading history.

James F. Hinrichs Insider Trading History at Acutus Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/15/2021Buy40,000$3.78$151,200.00View SEC Filing Icon  
See Full Table

James F. Hinrichs Buying and Selling Activity at Acutus Medical

This chart shows James F Hinrichs's buying and selling at Acutus Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acutus Medical Company Overview

Acutus Medical logo
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.
Read More

Today's Range

Now: $0.17
Low: $0.16
High: $0.19

50 Day Range

MA: $0.19
Low: $0.16
High: $0.26

2 Week Range

Now: $0.17
Low: $0.16
High: $1.09

Volume

729,302 shs

Average Volume

1,982,421 shs

Market Capitalization

$5.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.19